<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">CC</journal-id><journal-title-group><journal-title>Computational Chemistry</journal-title></journal-title-group><issn pub-type="epub">2332-5968</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/cc.2020.81001</article-id><article-id pub-id-type="publisher-id">CC-96527</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Mechanistic Study of Anticancer Activity of Some Known Aminopyrimidoisoquinolinequinones via QSAR Classification Methodology
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Osman Elfaki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mukhtaar</surname><given-names>Qaaed S. Sultan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Inas</surname><given-names>Osman Khojali Mohammed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Chemistry and Industrial Chemistry, Faculty of Applied and Industrial Sciences, University of Bahri, Khartoum, Sudan</addr-line></aff><aff id="aff1"><addr-line>Department of Basic Science, Faculty of Engineering Sciences, Omdurman Islamic University, Omdurman, Sudan</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>11</month><year>2019</year></pub-date><volume>08</volume><issue>01</issue><fpage>1</fpage><lpage>13</lpage><history><date date-type="received"><day>2,</day>	<month>October</month>	<year>2019</year></date><date date-type="rev-recd"><day>19,</day>	<month>November</month>	<year>2019</year>	</date><date date-type="accepted"><day>22,</day>	<month>November</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The impact of lipophilicity as represented by the logarithm of octanol/water partition coefficient (logP), the combined steric/polarizability effect as represented by molar refractivity (MR) and bulk as represented by molar volume (MV) on the biological activity of 29 known aminopyrimidoisoquinolinequinones APIQ were analyzed using quantitative structure activity relationships methodology (QSAR). The activity data chosen was the inhibitory concentration (IC
  <sub>50</sub>) against human gastric adenocarcinoma (AGS) cell line. On running regression analysis, the physicochemical parameters and IC50 show very weak correlations as evident by the low values of Pearson Correlation R
  <sup>2</sup> (0.1 to 0.2). Since the individual compounds show appreciable activity (ranging from 20 to 0.5 μM), classification was resorted to in order to expose mechanistic nesting subgroups. This was done by clustering data points around various trend lines extracted from the scattered plot relating parameters to activity using R
  <sup>2</sup> as an index. The correlation of IC
  <sub>50</sub> versus MV was chosen a base of classification owing to higher statistical metrics it yield. This gave five regression lines, each of which is believed to represent a separate mechanistic profile. Additional descriptors were used to consolidate the clustering approach and to give depth to the assumed mechanistic profiles of each cluster.
 
</p></abstract><kwd-group><kwd>Aminopyrimidoisoquinolinequinones</kwd><kwd> QSAR</kwd><kwd> Classification Analysis</kwd><kwd>  Mechanistic Profile</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The quinone moiety has been showed to possess anticancer activity and numerous cancer drugs in clinical use contain this unit since the discovery of daunorubicin (daunomycin 1a) and adriamycin (doxorubicin 1b) in 1960’s [<xref ref-type="bibr" rid="scirp.96527-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref3">3</xref>]. These two compounds are commonly used clinical agents in the therapy of various types of cancers (hematologic, solid tumors, …, etc.) [<xref ref-type="bibr" rid="scirp.96527-ref4">4</xref>]. They belong to anthracycline class of compounds which are featured by anthracene-9,10-dione chromophore to which is fused a six-membered alicyclic ring with a carbethoxy group at C9 and a sugar moiety at C7 [<xref ref-type="bibr" rid="scirp.96527-ref5">5</xref>].</p><disp-formula id="scirp.96527-formula1"><graphic  xlink:href="//html.scirp.org/file/1-1710120x2.png"  xlink:type="simple"/></disp-formula><p>These compounds are naturally occurring antibiotic isolated from cultures of streptomyces species [<xref ref-type="bibr" rid="scirp.96527-ref2">2</xref>]. They relate to tetracycline antibiotics but are far more toxic. Drawbacks of anthracycline therapy include, among others, pronounced dose-dependent cardiotoxicity (heart failure in some patients) stem from generationof hydrogen peroxide and reactive oxygen species (ROS) through redox cycling [<xref ref-type="bibr" rid="scirp.96527-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref7">7</xref>]. This is also true for ametantrone 2a, which is a derivative of anthraquinone (anthracene-9-10-diones), that has high cardiotoxicity riskand mitoxantrone 2b, another synthetic derivative of anthracene-9-10-dionewhich induces an acute myocarditis and arrhythmia during infusion [<xref ref-type="bibr" rid="scirp.96527-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref9">9</xref>].</p><disp-formula id="scirp.96527-formula2"><graphic  xlink:href="//html.scirp.org/file/1-1710120x3.png"  xlink:type="simple"/></disp-formula><p>Pixantrone 3 is a modified ametantroneazaanolgue where the C-atom at position 9 was replaced by N-atom. It was proved to have anticancer activity with lower cardiotoxicity. This drug, however, fail to obtain FDA approval in the USA due to inconsistence of Phase II and Phase III data regarding cardiotoxicity. Recent studies shades doubts about its alleged reduced cardiotoxicity [<xref ref-type="bibr" rid="scirp.96527-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref11">11</xref>].</p><disp-formula id="scirp.96527-formula3"><graphic  xlink:href="//html.scirp.org/file/1-1710120x4.png"  xlink:type="simple"/></disp-formula><p>Research efforts were directed toward obtaining better agents in an attempt to mitigate the cardiotoxicity of the initial anthracycline exposure, thereby preserving the myocardial integrity [<xref ref-type="bibr" rid="scirp.96527-ref12">12</xref>]. Chromophore modification to alleviate cardiotoxicity yielded anthrapyrazoles and their aza analogues4, which related to ametantrone and mitoxantrone. The most active compounds from these categories is losoxantrone 4a, which is an anthrapyrazole, and BBR3438 4b which is an aza anthrapyrazole. The modification includes the incorporation of a pyrazole ring converting the quinone moiety into quasi quinone and, in case of aza analogues, incorporation of an N atom in position 9 [<xref ref-type="bibr" rid="scirp.96527-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref14">14</xref>].</p><disp-formula id="scirp.96527-formula4"><graphic  xlink:href="//html.scirp.org/file/1-1710120x5.png"  xlink:type="simple"/></disp-formula><p>Angucyclinones 5a are aromatic polyketides and naturally occurring biologically active angular benz (a) anthrathene-9,10-dione derivatives [<xref ref-type="bibr" rid="scirp.96527-ref15">15</xref>]. They look like the anthracyclines in that they are naturally occurring isolated from numerous strains of Streptomyces [<xref ref-type="bibr" rid="scirp.96527-ref16">16</xref>], in addition to their derivation from the same chromophore. They show antifungal, antiviral, antibiotic, antitumor activities [<xref ref-type="bibr" rid="scirp.96527-ref17">17</xref>]. The capability of modification in the angucyclinones rouses arouses a considerable interest in their synthesis toward development of a new antitumor drug [<xref ref-type="bibr" rid="scirp.96527-ref18">18</xref>].</p><disp-formula id="scirp.96527-formula5"><graphic  xlink:href="//html.scirp.org/file/1-1710120x6.png"  xlink:type="simple"/></disp-formula><p>Reports about the aza analogues 5b of angucyclinone are less common and are due mainly to Valderrama [<xref ref-type="bibr" rid="scirp.96527-ref19">19</xref>]. These workers synthesized a number of azaanalogues of angucyclinone which show good activity when tested against a panel of cancer cell lines. The same group reported the synthesis and anticancer evaluation of two groups of tricyclic aza analogues with ring D removed. The angular ring isdimethylprimidodione in one group, (8-aminopyrimido [4,5-c] isoquinolinequinones, APIQ’s) [<xref ref-type="bibr" rid="scirp.96527-ref20">20</xref>] anda cyclohexanone in the other (8- and 9-phenylamino-3,4-tetrahydro-phenanthridine-1,7,10 (2H)-triones, PPT) [<xref ref-type="bibr" rid="scirp.96527-ref21">21</xref>]. Both groups show comparable activity which is generally better than that of angucyclinones. In this paper we study the activity of APIQ’s in attempt to expose mechanistic aspects via Quantitative structure-activity relationships (QSAR) mythology.</p><p>QSAR is a mature scientific discipline which aids to find a mathematical relationship between the biological response of a series of congeneric molecules and various aspects of molecular behavior encoded by numerous molecular descriptors or physicochemical parameters [<xref ref-type="bibr" rid="scirp.96527-ref22">22</xref>]. To that end, computational methods become an indispensable tool for drug designers to obtain molecular descriptors and to derive the mathematical correlation [<xref ref-type="bibr" rid="scirp.96527-ref23">23</xref>].</p><p>If the sole purpose of a model is prediction of activity of related untested compounds, regression analysis is used, but if the purpose of analysis is to categorize data according to a specific criterion, then classification methods is resorted to. There are several algorithms to perform each of these types of QSAR analyses. Regression could be done by linear regression, partial least squire regression, principle component analysis among others. Classification, on the other hand, could be performed by decision tree, random forest, K-nearest neighbor and regression clustering [<xref ref-type="bibr" rid="scirp.96527-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.96527-ref25">25</xref>]. The principle of classification analysis is to break down a larger data set with poor correlation metrics into smaller subsets with much improved metrics [<xref ref-type="bibr" rid="scirp.96527-ref26">26</xref>]. Regression clustering could be used in mechanistic study to furnish the attractive features of explaining the variabilities of descriptors with response. Linear regression and regression clustering are used in the present study to extract information about predictive ability and about hidden mechanistic trends of a data set of 29 known aminopyrimidoisoquinolinequinones (APIQ’s).</p></sec><sec id="s2"><title>2. Method and Material</title><p>Drawing of structures and calculating the descriptors was carried out using ACDlab/chemsketchfreeware2015.2.5, Arguslab 4 and Molecular operation environment (MOE) 2008 software. The descriptors used in the present study include the logarithm of octanol/water partition coefficient (Log P), moler volume (MV), molar refractivity (MR), sum of atomic polarizabilities (apol), electrophilicity index (ω), surface rugosity (Rug) and hydrogen bond donor capacity (HBD). Statistical analysis was performed using Microsoft Excel 2010 program. Classification through regression clustering was performed as we described before [<xref ref-type="bibr" rid="scirp.96527-ref27">27</xref>]. The biological activity used in the present study is the anticancer activities of compounds 1-29 against human gastric adenocarcinoma (AGS) cell line which were taken from literature (Vasquez et al. 2010). <xref ref-type="table" rid="table1">Table 1</xref> below shows the structures of compounds used in the present study.</p><p>The molecular descriptors and biological activity data of APIQ’s are shown in <xref ref-type="table" rid="table2">Table 2</xref> below.</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Chemical structures of aminopyrimidoisoquinolinequinones (APIQ’s)</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >No</th><th align="center" valign="middle" >R1</th><th align="center" valign="middle" >R2</th><th align="center" valign="middle" >R3</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Me-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Hp-HO-Ph-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Hp-MeO-Ph-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Hp-F-Ph-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Ho-MeOph-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >o-F-Ph-</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Ho,m-diMeO-Ph-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Et</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >n-But</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Morpholinyl</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Hcyclohexyl</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >adamantanyl</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >p-HO-Ph-</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >p-MeO-Ph-</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >p-F-Ph-</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >p-nitro-ph-</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >o-MeO-Ph-</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >o-F-Ph-</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >o,m-diMeO-Ph-</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >Et</td><td align="center" valign="middle" >Ph-</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >n-But</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >Morpholinyl</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >cyclohexyl</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >Me</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >adamantanyl</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Molecular descriptors and biological activity data of compounds 1 - 29</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No</th><th align="center" valign="middle" >LogP</th><th align="center" valign="middle" >MR</th><th align="center" valign="middle" >MV</th><th align="center" valign="middle" >IC<sub>50</sub> (AGS<sup>*</sup>) (μM)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >−0.35</td><td align="center" valign="middle" >65.36</td><td align="center" valign="middle" >177.7</td><td align="center" valign="middle" >75.2</td></tr><tr><td align="center" valign="middle" >2<sup> </sup></td><td align="center" valign="middle" >0.11</td><td align="center" valign="middle" >70.19</td><td align="center" valign="middle" >193.9</td><td align="center" valign="middle" >82.1</td></tr><tr><td align="center" valign="middle" >3<sup> </sup></td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >94.59</td><td align="center" valign="middle" >240.6</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >4<sup> </sup></td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >96.47</td><td align="center" valign="middle" >239</td><td align="center" valign="middle" >15.5</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.7<sup> </sup></td><td align="center" valign="middle" >101.26</td><td align="center" valign="middle" >264.6</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1.19</td><td align="center" valign="middle" >94.58</td><td align="center" valign="middle" >244.8</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >7<sup> </sup></td><td align="center" valign="middle" >0.64</td><td align="center" valign="middle" >101.26</td><td align="center" valign="middle" >264.6</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.71</td><td align="center" valign="middle" >94.58</td><td align="center" valign="middle" >244.8</td><td align="center" valign="middle" >5.2</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.95<sup> </sup></td><td align="center" valign="middle" >107.94</td><td align="center" valign="middle" >288.6</td><td align="center" valign="middle" >9.1</td></tr><tr><td align="center" valign="middle" >10<sup> </sup></td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >99.29</td><td align="center" valign="middle" >259.1</td><td align="center" valign="middle" >2.1</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1.42</td><td align="center" valign="middle" >103.92</td><td align="center" valign="middle" >275.6</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >87.57</td><td align="center" valign="middle" >242</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.33</td><td align="center" valign="middle" >87.02</td><td align="center" valign="middle" >237.9</td><td align="center" valign="middle" >4.6</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1.46</td><td align="center" valign="middle" >94.77</td><td align="center" valign="middle" >256.2</td><td align="center" valign="middle" >NA**</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >2.28</td><td align="center" valign="middle" >109.17</td><td align="center" valign="middle" >284.8</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >1.21</td><td align="center" valign="middle" >99.41</td><td align="center" valign="middle" >256.9</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >0.46</td><td align="center" valign="middle" >101.29</td><td align="center" valign="middle" >255.3</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >1.16</td><td align="center" valign="middle" >106.09</td><td align="center" valign="middle" >280.9</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >1.65</td><td align="center" valign="middle" >99.4</td><td align="center" valign="middle" >261.1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >1.66</td><td align="center" valign="middle" >105.96</td><td align="center" valign="middle" >268.7</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >106.09</td><td align="center" valign="middle" >280.9</td><td align="center" valign="middle" >&gt;100</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >1.17</td><td align="center" valign="middle" >99.4</td><td align="center" valign="middle" >261.1</td><td align="center" valign="middle" >1.9</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >1.41</td><td align="center" valign="middle" >112.77</td><td align="center" valign="middle" >304.9</td><td align="center" valign="middle" >31.7</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >1.34</td><td align="center" valign="middle" >104.11</td><td align="center" valign="middle" >275.4</td><td align="center" valign="middle" >4.7</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >1.88</td><td align="center" valign="middle" >108.75</td><td align="center" valign="middle" >291.9</td><td align="center" valign="middle" >19.2</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >1.45</td><td align="center" valign="middle" >92.19</td><td align="center" valign="middle" >257.7</td><td align="center" valign="middle" >5.2</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >0.79</td><td align="center" valign="middle" >91.85</td><td align="center" valign="middle" >254.1</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >1.92</td><td align="center" valign="middle" >99.39</td><td align="center" valign="middle" >271.9</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >2.74</td><td align="center" valign="middle" >113.79</td><td align="center" valign="middle" >300.4</td><td align="center" valign="middle" >4.2</td></tr></tbody></table></table-wrap><p>AGS* human gastric adenocarcinoma cell line; NA** = not available.</p></sec><sec id="s3"><title>3. Results and Discussion</title><p>1) Regression analysis of log P, MR, MV and their combination versus IC<sub>50</sub></p><p>Biological activity data was first curated by removing problematic data points. These are namely points 1 and 2 because of their high standard error of the mean; point 14 for which no datum is available (NA) and point 21 for which the value is not specified (&gt;100). The rest of data points were used to develop QSAR equations. We run both simple and multiple linear regressions to find the degree of correlation of each parameter with IC<sub>50</sub> and that of them, combining two at a time, with IC<sub>50</sub>. The combination of two parameters is done after referring to their correlation matrix (<xref ref-type="table" rid="table3">Table 3</xref> below).</p><p>LogP could be combined with both MR and MV owing to its low collinearity with each of them (R<sup>2</sup> = 0.36 and 0.48 respectively). MR and MV cannot, however, be combined in one and the same equation owing to their collinearity (R<sup>2</sup> = 0.8). The resulting equations are as follows:</p><p>Correlation of logP versus IC<sub>50</sub>:</p><p>IC 50 = − 0.2444 logP + 5.97 (1)</p><p>n = 25, R<sup>2</sup> = 0.00048, S = 7.04, F = 0.0111</p><p>Correlation of MR versus IC<sub>50</sub>:</p><p>IC 50 = 0.372 MR − 31.68 (2)</p><p>n = 25, R<sup>2</sup> = 0.15, S = 6.5, F = 4.04</p><p>Correlation of MV versus IC<sub>50</sub></p><p>IC 50 = 0.161 MV − 36.862 (3)</p><p>n = 25, R<sup>2</sup> = 0.2, S = 6.308, F = 5.7</p><p>Correlation of both logP and MR versus IC<sub>50</sub></p><p>IC 50 = 0.598 MR − 4.376 logP − 49.227 (4)</p><p>n = 25, R<sup>2</sup> = 0.25, S = 6.243, F = 3.646</p><p>Correlation of both logP and MV versus IC<sub>50</sub></p><p>IC 50 = 0.32 MV − 7.08 logP − 70.613 (5)</p><p>n = 25, R<sup>2</sup> = 0.41. S = 5.54, F = 7.622.</p><p>Equations (1)-(5) indicate that the models are not predictive as evident from poor statistical materics. Equation (1) represents correlation between lipophilicity measured by logP and biological response. The nearly zero value for Pearson coefficient (R<sup>2</sup>) indicates that the variation in biological activity of APIQ’s is totally independent from variation in lipophilicity. MR is a descriptor of both polarizability and volume of the molecule and it accounts for about 15% (R<sup>2</sup> = 0.15, Equation (2)) of the variation of biological activity. Owing to the higher contribution of MV in explaining the variation of biological activity (~20%, Equation (3)), it seems that the presence of a term for molecular polarizability in the expression of MR lower overall contribution in explaining the variability of the biological response. Combination of LogP and MR give improved correlation</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Correlation matrix of descriptors and response</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >LogP</th><th align="center" valign="middle" >MR</th><th align="center" valign="middle" >MV</th><th align="center" valign="middle" >IC50 (AGS)</th></tr></thead><tr><td align="center" valign="middle" >LogP</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >MR</td><td align="center" valign="middle" >0.36</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >MV</td><td align="center" valign="middle" >0.48</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >IC<sub>50</sub> (AGS)</td><td align="center" valign="middle" >0.000483</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap><p>(25% explained variability). Abetter correlation was obtained by combining logP with MV (41% explained variability). Still the model could not be used for predictive purposes. Individual compounds exhibit appreciable activity against cancer although the present sets of descriptors could not capture the variability of the biological activity. This may result from the existence of various subgroupshidden in the main dataset, which oppose each other leading to weakening of a unifying trend line correlating the descriptors with their response. These descriptors could, therefore, be used to expose these supposed subgroups. This is done through classification.</p><p>2) Classification analysis</p><p>Each of data set used to develop Equations (1)-(3) above, were subjected to a process of simple clustering described before [<xref ref-type="bibr" rid="scirp.96527-ref27">27</xref>]. The clustering was based on each of the parameters in turns. Upon scrutiny, we choose the clustering based on MV to explore mechanistic trends. The reasons for this choice are: 1) MV gave us the highest R<sup>2</sup> value in regression analysis of the original data set (R<sup>2</sup> = 0.2); 2) it gave five clusters each containing five data points therefore obeying the rule of thumb of QSAR (5 data points for each parameter). The regression clustering output thus obtained is shown in <xref ref-type="table" rid="table4">Table 4</xref> below.</p><p>The regression lines along which data points of each clusterlie are illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref> below.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Statistical metrics for clustering based on (MV)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Clusters</th><th align="center" valign="middle" >Data Points</th><th align="center" valign="middle" >Equation (Linear)</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >R<sup>2</sup></th><th align="center" valign="middle" >S</th><th align="center" valign="middle" >F</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >7, 10, 16, 22, 25</td><td align="center" valign="middle" >IC<sub>50</sub> = 0.532MV − 136.2</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >0.7</td><td align="center" valign="middle" >480</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5, 17, 18, 19, 23</td><td align="center" valign="middle" >IC<sub>50</sub> = 0.588MV − 152.0</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.84</td><td align="center" valign="middle" >5.9</td><td align="center" valign="middle" >15.74</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4, 11, 15, 24, 26</td><td align="center" valign="middle" >IC<sub>50</sub> = −0.269MV+ 77.98</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >−0.86</td><td align="center" valign="middle" >2.33</td><td align="center" valign="middle" >17.76</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3, 6, 8, 9, 12</td><td align="center" valign="middle" >IC<sub>50</sub> = 0.129MV − 28.23</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >1.12</td><td align="center" valign="middle" >22.45</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >13, 20, 27, 28, 29</td><td align="center" valign="middle" >IC<sub>50</sub> = −0.011MV + 6.279</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >−0.03</td><td align="center" valign="middle" >1.73</td><td align="center" valign="middle" >0.09</td></tr></tbody></table></table-wrap><p>It is noticed that cluster 5 is not depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref> above owing to the poorness of its MV/IC<sub>50</sub> correlation as evident from the R<sup>2</sup> value (−0.03). In order to justify our classification, we selected some other parameters which reflect different aspects of molecular behavior. These include, in addition to logP, sum of atomic polarizabilities (apol) to describe dispersion forces such as van der Waal interaction; surface rugosity or roughness (Rug) to follow surface topology of the legend; hydrogen bond donor capacity HBD to capture the ability of legend to act as a donor in hydrogen bonding with receptor and electrophilicity index ω which reflects the ability of legend to act as an electrophile accepting electrons from the receptor. All the above described descriptors were regressed against IC<sub>50</sub> both linearly and parabolically and Pearson coefficients are collected in <xref ref-type="table" rid="table5">Table 5</xref> below.</p><p>The presence of mechanistic subgroup nested in APIQ data set could be justified by examining <xref ref-type="table" rid="table5">Table 5</xref> above. We are going to discuss the variation of biological activity with each parameter for clusters 1 - 5, one at time, to demark the mechanistic difference among these clusters.</p><p>Sum of atomic polarizabilities (apol): this could be considered as an indicator of dispersion interaction of APIQ’s with their receptor [<xref ref-type="bibr" rid="scirp.96527-ref28">28</xref>]. <xref ref-type="fig" rid="fig2">Figure 2</xref> below shows the plots of apol vs IC<sub>50</sub> for each cluster exhibited side by side for easy comparison. It could be seen from the plots that clusters 1, 2 and 4 show high association between apol and IC<sub>50</sub> ( R L 2 = 0.99 , 0.87 and 0.86 respectively) but they traverse different response space; cluster 1 exists between (0 - 20) response units while cluster 2 exists between (~0 - 30) response unit; cluster 4 exists between (2 - 10) response units. For these clusters the response is directly proportional to descriptor. Cluster 3 shows moderate association between the descriptor and the response ( R L 2 = − 0.53 ) and spans between (0 - 15) response units. The response has an inverse proportionality to descriptor in cluster 3. No linear</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Pearson coefficient for correlation between IC<sub>50</sub> and selected parameters for clusters 1 - 5</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Descriptors</th><th align="center" valign="middle" >Cluster 1</th><th align="center" valign="middle" >Cluster 2</th><th align="center" valign="middle" >Cluster 3</th><th align="center" valign="middle" >Cluster 4</th><th align="center" valign="middle" >Cluster 5</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Apol</td><td align="center" valign="middle" >R L 2 0.99</td><td align="center" valign="middle" >R L 2 0.87</td><td align="center" valign="middle" >R L 2 −0.53</td><td align="center" valign="middle" >R L 2 0.86</td><td align="center" valign="middle" >R L 2 −0.00</td></tr><tr><td align="center" valign="middle" >R P 2 0.99</td><td align="center" valign="middle" >R P 2 0.99</td><td align="center" valign="middle" >R P 2 0.75</td><td align="center" valign="middle" >R P 2 −0.86</td><td align="center" valign="middle" >R P 2 0.79</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Rug</td><td align="center" valign="middle" >R L 2 0.79</td><td align="center" valign="middle" >R L 2 0.97</td><td align="center" valign="middle" >R L 2 −0.33</td><td align="center" valign="middle" >R L 2 0.61</td><td align="center" valign="middle" >R L 2 0.02</td></tr><tr><td align="center" valign="middle" >R P 2 0.95</td><td align="center" valign="middle" >R P 2 0.98</td><td align="center" valign="middle" >R P 2 −0.86</td><td align="center" valign="middle" >R P 2 0.94</td><td align="center" valign="middle" >R P 2 0.83</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HBD</td><td align="center" valign="middle" >R L 2 −0.67</td><td align="center" valign="middle" >R L 2 −0.52</td><td align="center" valign="middle" >R L 2 0.81</td><td align="center" valign="middle" >R L 2 −0.16</td><td align="center" valign="middle" >R L 2 0.03</td></tr><tr><td align="center" valign="middle" >R P 2 0.94</td><td align="center" valign="middle" >R P 2 0.93</td><td align="center" valign="middle" >R P 2 0.95</td><td align="center" valign="middle" >R P 2 0.29</td><td align="center" valign="middle" >R P 2 0.56</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Ѡ</td><td align="center" valign="middle" >R L 2 −0.03</td><td align="center" valign="middle" >R L 2 0.87</td><td align="center" valign="middle" >R L 2 −0.10</td><td align="center" valign="middle" >R L 2 0.05</td><td align="center" valign="middle" >R L 2 0.14</td></tr><tr><td align="center" valign="middle" >R P 2 −0.09</td><td align="center" valign="middle" >R P 2 0.99</td><td align="center" valign="middle" >R P 2 −0.38</td><td align="center" valign="middle" >R<sup>2</sup><sub>P</sub> −0.03</td><td align="center" valign="middle" >R P 2 0.14</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >LogP</td><td align="center" valign="middle" >R L 2 0.63</td><td align="center" valign="middle" >R L 2 0.11</td><td align="center" valign="middle" >R L 2 −0.92</td><td align="center" valign="middle" >R L 2 −0.01</td><td align="center" valign="middle" >R L 2 −0.08</td></tr><tr><td align="center" valign="middle" >R P 2 0.99</td><td align="center" valign="middle" >R P 2 −0.21</td><td align="center" valign="middle" >R P 2 0.99</td><td align="center" valign="middle" >R P 2 −0.16</td><td align="center" valign="middle" >R P 2 0.84</td></tr></tbody></table></table-wrap><p>correlation is to be found between the descriptor and the response in case of cluster 5 ( R L 2 ≈ 0 ). All the above arguments indicate the existence of different mechanistic profiles among our five clusters of APIQ’s as far as dispersion interaction-represented by apol is concerned.</p><p>Both linear and parabolic fittings are similar for clusters 1 and 4; R L 2 = R P 2 = 0.99 for cluster 1, compared to R L 2 = 0.86 and R P 2 = − 0.86 for cluster 4. For the rest of clusters, the parabolic fitting gives higher R<sup>2</sup> compared to linear fitting. This is dramatically borne out by cluster 5 where R<sup>2</sup> rises from 0.00 for linear fitting to almost 0.79 for parabolic fitting. Similarly, for cluster 2 the rise in R<sup>2</sup> is also sharp; 0.87 for linear to 0.99 for parabolic. Cluster 3 exhibits a milder increase; R L 2 = − 0.53 to R P 2 = 0.75 . The foregoing argument implies that for clusters 3 and 5, the descriptor apol explains the variability in the biological response in non-linear manner. The overall good linear and/or parabolic correlations indicate that the distribution of electron along the entire volume of the legend has something to complement with inside the receptor pocket.</p><p>Surface rugosity (Rug) is a descriptor for molecular surface roughness. It represents the ratio of volume to surface. The smaller the ratio is, the larger the rugosity [<xref ref-type="bibr" rid="scirp.96527-ref29">29</xref>]. It is apparent from <xref ref-type="table" rid="table5">Table 5</xref> above that the correlation between Rug and IC<sub>50</sub> is parabolic rather than linear for all clusters ( R P 2 = 0.95 , 0.98, −0.86, 0.94 and 0.83 for 1, 2, 3, 4 and 5 respectively).</p><p>Hydrogen bond donor capacity HBD: expressed in terms of the number of possible hydrogen-bond donors [<xref ref-type="bibr" rid="scirp.96527-ref29">29</xref>]. This is inversely correlated with the response for clusters 1, 2, and 4 and directly correlated with the response for clusters 3 and 5. Again the relations are parabolic rather than linear. Clusters 1, 2 and 3 show high positive non-linear (parabolic) correlations ( R P 2 = 0.94 , 0.93 and 0.95 respectively) while cluster 4 shows a poor positive non-linear correlation ( R P 2 = 0.29 ). Cluster 5 shows a moderate ( R P 2 = 0.56 ) positive correlation.</p><p>Electrophilicity index ω: measures the tendency of a molecule as a whole to accommodate electrons [<xref ref-type="bibr" rid="scirp.96527-ref29">29</xref>]. The descriptor ω shows very poor correlation for all the clusters with exception to cluster 2 which exhibits very good correlation both linearly ( R L 2 = 0.87 ) and parabolically ( R P 2 = 0.99 ). Upon contemplating the structures of the member compounds of this cluster we noticed that four of them (5, 17, 18 and 19) carry a strong electronegative groups at the para position of aniline ring attached at C8 of the parent molecules; namely methoxy, hydroxy, methoxy and flouro respectively. The fifth compound (compound 23) carries two methoxy groups at ortho and meta positions. It seems that the presence of these electronegative atoms in these compounds increase their ability to accommodate electrons hence the compliance between ω and the observation (presence of electronegative atoms) discussed above. This fits nicely with our finding and gives a good credit for our clustering methodology. We can add a comment about the complimentary receptor site receiving such molecules; which must be nucleophilic, capable of donating electrons to be accommodated by our compounds. A detailed quantum mechanical study of electronic disposition of the compounds of cluster 2 will be published in a separate paper.</p><p>Logarithm of octanol/water partition coefficient Log P: this parameter shows high linear and/or parabolic correlations with the response for clusters 1 ( R L 2 = 0.63 , R P 2 = 0.99 ), cluster 3 ( R L 2 = − 0.92 , R P 2 = 0.99 ) and cluster 5 ( R L 2 = − 0.08 , R P 2 = 0.844 ). For clusters 2 and cluster 4 the correlations are very poor ( R L 2 = 0.11 and −0.01 respectively).</p></sec><sec id="s4"><title>4. Conclusion</title><p>We conclude that for this particular group of APIQ’s, the absence of universal correlation between their anticancer activity and the descriptors for lipophilicity and volume/polarizability is due to presence of nesting subgroups exhibiting varied mechanistic profiles. We have used a simple clustering method to segregate the data set into 5 clusters, each of which fits a separate trend line based on MV. We used five descriptors to emphasize the divergence of APIQ’s into distinct mechanistic profiles.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Elfaki, M.O., Sultan, M.Q.S. and Mohammed, A.I.O.K. (2020) Mechanistic Study of Anticancer Activity of Some Known Aminopyrimidoisoquinolinequinones via QSAR Classification Methodology. Computational Chemistry, 8, 1-13. https://doi.org/10.4236/cc.2020.81001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.96527-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Tambama, P., Abegaz, B. and Mukanganyama, S. (2014) Antiproliferative Activity of the Isofuranonaphthoquinone Isolated from Bulbine Frutescens against Jurkat T Cell. BioMed Research International, 2014, Article ID: 752941. https://doi.org/10.1155/2014/752941</mixed-citation></ref><ref id="scirp.96527-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Wakharde, A.A., Awad, A.H., Bhagat, A. and Karuppayil, S.M. (2018) Synergistic Activation of Doxorubicin against Cancer: A Review. American Journal of Clinical Microbiology and Antimicrobials, 1, 1-6. http://www.remedypublications.com</mixed-citation></ref><ref id="scirp.96527-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Patrick, G.L. (2013) An Introduction to Medicinal Chemistry. 5th Edition, Oxford University Press, Oxford, 524.</mixed-citation></ref><ref id="scirp.96527-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Sauter, K.A.D., Wood, L.J., Wong, J., Iordanov, M. and Magun, B.E. (2011) Doxorubicin and Daunorubicin Induce Processing and Release of Interleukin-1β through Activation of the NLRP3 Inflammasome. Cancer Biology &amp; Therapy, 11, 1008-1016. https://doi.org/10.4161/cbt.11.12.15540</mixed-citation></ref><ref id="scirp.96527-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. and Gianni, L. (2004) Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacological Reviews, 56, 185. https://doi.org/10.1124/pr.56.2.6</mixed-citation></ref><ref id="scirp.96527-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Cai, F.F., et al. (2019) Anthracycline-Induced Cardiotoxicity in the Chemotherapy Treatment of Breast Cancer: Preventive Strategies and Treatment (Review). Molecular and Clinical Oncology, 11, 15.</mixed-citation></ref><ref id="scirp.96527-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Xu, X., Persson, H.L. and Richardson, D.R. (2005) Molecular Pharmacology of the Interaction of Anthracyclines with Iron. Molecular Pharmacology, 68, 261. https://doi.org/10.1124/mol.105.013383</mixed-citation></ref><ref id="scirp.96527-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S. and Noonan, D.M. (2010) Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. Journal of the National Cancer Institute, 102, 14. https://doi.org/10.1093/jnci/djp440</mixed-citation></ref><ref id="scirp.96527-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Year, R.A.M., Pérez L.S. and Díaz, A.T. (2018) Chemotherapy-Induced Cardiotoxicity. CorSalud, 10, 68. http://www.revcorsalud.sld.cu</mixed-citation></ref><ref id="scirp.96527-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Avenda&amp;ntilde;o, C. and Menéndez, J.C. (2015) Medicinal Chemistry of Anticancer Drugs. 2nd Edition, Elsevier, Amsterdam, 305.</mixed-citation></ref><ref id="scirp.96527-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Reis-Mendes, A., Alves, M., Valho, F.C., Remi&amp;atilde;o, F., Bastos, M.L. and Costa, V.M. (2018) Pixantrone, a New Anticancer Drug with the Same Old Cardiac Problems? An in Vitro Study with Differentiated and Non-Differentiated H9c2 Cells. Interdisciplinary Toxicology, 11, 13. https://doi.org/10.2478/intox-2018-0002</mixed-citation></ref><ref id="scirp.96527-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Rahman, A.M., Yusuf, S.W. and Ewer, M.S. (2007) Anthracycline-Induced Cardiotoxicity and the Cardiac-Sparing Effect of Liposomal Formulation. International Journal of Nanomedicine, 2, 567.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676818</mixed-citation></ref><ref id="scirp.96527-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Sissi, C., Moro, S., Richter, S., Gatto, B., Menta, E., Spinelli, S., Krapcho, A.P., Zunino, F. and Palumbo, M. (2000) DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action. Molecular Pharmacology, 59, 96. https://doi.org/10.1124/mol.59.1.96</mixed-citation></ref><ref id="scirp.96527-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kumar, H., Saini, D., Jain, S. and Jain, N. (2013) Pyrazole Scaffold: A Remarkable Tool in the Development of Anticancer Agents. European Journal of Medicinal Chemistry, 70, 248. https://doi.org/10.1016/j.ejmech.2013.10.004</mixed-citation></ref><ref id="scirp.96527-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ma, M., Rateb, M.E., Teng, Q.H., Yang, D., Rudolf, J.D., Zhu, X.C., Huang, Y., Zhao, L.-X., Jiang, Y., Li, X.L., Rader, C., Duan, Y.W. and Shen, B. (2015) Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion. Journal of Natural Products, 78, 2471. https://doi.org/10.1021/acs.jnatprod.5b00601</mixed-citation></ref><ref id="scirp.96527-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Xie, Z.P., Liu, B., Wang, H.P., Yang, S.X., Zhang, H.Y., Wang, Y.P., Ji, N.Y., Qin, S. and Laatsch, H. (2012) Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp. Mar. Drugs, 10, 551. https://doi.org/10.3390/md10030551</mixed-citation></ref><ref id="scirp.96527-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Cuellar, M., Qui&amp;ntilde;ones, N., Villena, J. and Salas, C. (2013) Synthesis and Citotoxicity Activity of New Aza-Analogues of Angucyclinones from (&amp;minus;)-Shikimic Acid. 15th BMOS, Vol. 1, 10. https://doi.org/10.5151/chempro-15bmos-BMOS2013_201382005353</mixed-citation></ref><ref id="scirp.96527-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Qui&amp;ntilde;ones, N., Hernández, S., Catalán, L.E., Villena, J., Brito, I., Cabrera, A.R., Salas, C.O. and Cuellar, M.A. (2018) (&amp;minus;)-Shikimic Acid as a Chiral Building Block for the Synthesis of New Cytotoxic 6-Aza-Analogues of Angucyclinones. Molecules, 23, 1422. https://doi.org/10.3390/molecules23061422</mixed-citation></ref><ref id="scirp.96527-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Vásquez, D., Rodríguez, J.A., Theoduloz, C., Verrax, J., Calderon, P.B. and Valderrama, J.A. (2009) Synthesis and Antitumor Evaluation of 8-Phenylaminopyrimido [4,5-c]isoquinolinequinones. Bioorganic &amp; Medicinal Chemistry Letters, 19, 5060. https://doi.org/10.1016/j.bmcl.2009.07.041</mixed-citation></ref><ref id="scirp.96527-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Vásquez, D., Rodriguez, J.A., Theoduloz, C., Calderon, P.B. and Valderrama, J.A. (2010) Studies on Quinones. Part 46. Synthesis and in Vitro Anti-Tumour Evaluation of Aminopyrimidoisoquinolinequinones. European Journal of Medicinal Chemistry, 45, 5234. https://doi.org/10.1016/j.ejmech.2010.08.040</mixed-citation></ref><ref id="scirp.96527-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Valderrama, J.A., Ibacache, A., Rodriguez, J.A., Theoduloz, C. and Benites, J. (2011) Studies on Quinones. Part 47. Synthesis of Novel Phenylaminophenanthridinequinones as Potential Anti-Tumour Agents. European Journal of Medicinal Chemistry, 46, 3398. https://doi.org/10.1016/j.ejmech.2011.05.003</mixed-citation></ref><ref id="scirp.96527-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Pathan, S., Ali, S.M. and Shrivastava, M. (2016) Quantitative Structure Activity Relationship and Drug Design: A Review. International Journal of Research in BioSciences, 5, 1. http://www.ijrbs.in</mixed-citation></ref><ref id="scirp.96527-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lo, Y.-C., Rensi, S.E., Torng, W. and Altman, R.B. (2018) Machine Learning in Chemoinformatics and Drug Discovery. Drug Discovery Today, 23, 1538. https://doi.org/10.1016/j.drudis.2018.05.010</mixed-citation></ref><ref id="scirp.96527-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Gramatica, P. (2013) On the Development and Validation of QSAR Models. Methods in Molecular Biology, 930, 499. https://doi.org/10.1007/978-1-62703-059-5_21</mixed-citation></ref><ref id="scirp.96527-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Roy, K., Das, S., et al. (2015) A Primer on QSAR/QSPR Modeling. Springer, Berlin. http://www.springer.com https://doi.org/10.1007/978-3-319-17281-1</mixed-citation></ref><ref id="scirp.96527-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Parmar, M. (2018) Comparative Analysis of Classification Techniques Using WEKA on Different Datasets. International Journal of Latest Engineering and Management Research, 3, 1. http://www.researchgate.net/publication/325872035</mixed-citation></ref><ref id="scirp.96527-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Hashim, H.A., El-Fakii, M.O. and Saeed, A.E.M. (2015) Anticancer Activity Trends of 5-Substituted 2 (2-Diethylamino)ethyl Anthrapyrazoles toward L1210 Murine Leukemia: A QSAR Analysis. Lebda Medical Journal, 1, 20. http://www.elmergib.edu.ly/euj/index.php/LMJ/index</mixed-citation></ref><ref id="scirp.96527-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Sarwar, M.W., Riaz, A., Dilshad, S.M.R., Al-Qahtani, A., Nawaz-Ul-Rehman, M.S. and Mubin, M. (2018) SAR and QSAR Studies Showed Plant Flavonoids as Potential Inhibitors of Dengue NS2B-NS3 Protease. BMC Structural Biology, 18, 6. https://doi.org/10.1186/s12900-018-0084-5</mixed-citation></ref><ref id="scirp.96527-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Todeschini, R. and Consonni, V. (2009) Molecular Descriptors for Chemoinformatics. 2nd Edition, Vol. 1, Wiley-VCH, Weinheim, 247, 362, 388, 629.</mixed-citation></ref></ref-list></back></article>